FOXP4 and esophageal squamous cell carcinoma: Application of the Kaplan–Meier method revealed a significant reduction in overall survival (OS) (Figure 1H) and recurrence-free survival (RFS) (Figure 1I) in 69 ESCC patients with high expression of FOXP4-AS1.